AAAAAA
Results: 1-25/30
Authors:
DALIFARD I
DAVER A
GOUSSARD J
LORIMIER G
GOSSEBRUN S
LORTHOLARY A
LARRA F
Citation: I. Dalifard et al., P185 OVEREXPRESSION IN 220 SAMPLES OF BREAST-CANCER UNDERGOING PRIMARY SURGERY - COMPARISON WITH C-ERBB-2 GENE AMPLIFICATION, INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 1(5), 1998, pp. 855-861
Authors:
GAMELIN E
BOISDRONCELLE M
LEBOUIL A
TURCANT A
CAILLEUX A
KRIKORIAN A
BRIENZA S
CVITKOVIC E
LARRA F
ROBERT J
ALLAIN P
Citation: E. Gamelin et al., DETERMINATION OF UNBOUND PLATINUM AFTER OXALIPLATIN ADMINISTRATION - COMPARISON OF CURRENTLY AVAILABLE METHODS AND INFLUENCE OF VARIOUS PARAMETERS, Anti-cancer drugs, 9(3), 1998, pp. 223-228
Authors:
DELVA R
GAMELIN E
LORTHOLARY A
MAILLART P
DELAJARRIGE PL
GIRAULT C
GUERIN J
LARRA F
Citation: R. Delva et al., SUPPRESSION OF HEPARINIZATION OF CENTRAL VENOUS CATHETERS BETWEEN CYCLES OF CHEMOTHERAPY - RESULTS OF A PHASE-I STUDY, Supportive care in cancer, 6(4), 1998, pp. 384-388
Authors:
DELVA R
LORTHOLARY A
GAMELIN E
MAILLART P
GUERIN O
LEYNIA P
BIVILLE F
LARRA F
Citation: R. Delva et al., EFFICACY OF CHEMOTHERAPY(CT) ADAPTATION ACCORDING TO PATHOLOGICAL RESPONSE AFTER PRIMARY CHEMOTHERAPY (PCT) FOR LOCALLY ADVANCED BREAST-CANCER (LABC), Annals of oncology, 9, 1998, pp. 600-600
Authors:
GAMELIN E
BOISDRONCELLE M
DELVA R
REGIMBEAU C
CAILLEUX PE
ALLEAUME C
MAILLET ML
GOUDIER MJ
SIRE M
PERSONJOLY MC
MAIGRE M
MAILLART P
FETY R
BURTIN P
LORTHOLARY A
DUMESNIL Y
PICON L
GESLIN J
GESTA P
DANQUECHINDORVAL E
LARRA F
ROBERT J
Citation: E. Gamelin et al., LONG-TERM WEEKLY TREATMENT OF COLORECTAL METASTATIC CANCER WITH FLUOROURACIL AND LEUCOVORIN - RESULTS OF A MULTICENTRIC PROSPECTIVE TRIAL OF FLUOROURACIL DOSAGE OPTIMIZATION BY PHARMACOKINETIC MONITORING IN 152 PATIENTS, Journal of clinical oncology, 16(4), 1998, pp. 1470-1478
Authors:
GOSSEBRUN S
SAUVAIGO S
DAVER A
LARRA F
KWIATKOWSKI F
BIGNON YJ
BERNARDGALLON D
Citation: S. Gossebrun et al., ASSOCIATION BETWEEN H-RAS MINISATELLITE AND COLORECTAL-CANCER RISK, Anticancer research, 18(4A), 1998, pp. 2611-2616
Authors:
MURATET JP
DAVER A
MINIER JF
LARRA F
Citation: Jp. Muratet et al., INFLUENCE OF SCANNING DOSES OF I-131 ON SUBSEQUENT FIRST ABLATIVE TREATMENT OUTCOME IN PATIENTS OPERATED ON FOR DIFFERENTIATED THYROID-CARCINOMA, The Journal of nuclear medicine, 39(9), 1998, pp. 1546-1550
Authors:
GAMELIN E
BOISDRONCELLE M
TURCANT A
LARRA F
ALLAIN P
ROBERT J
Citation: E. Gamelin et al., RAPID AND SENSITIVE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS OF HALOGENOPYRIMIDINES IN PLASMA, Journal of chromatography B. Biomedical sciences and applications, 695(2), 1997, pp. 409-416
A SIMPLE CHROMATOGRAPHIC METHOD FOR THE ANALYSIS OF PYRIMIDINES AND THEIR DIHYDROGENATED METABOLITES
Authors:
GAMELIN E
BOISDRONCELLE M
LARRA F
ROBERT J
Citation: E. Gamelin et al., A SIMPLE CHROMATOGRAPHIC METHOD FOR THE ANALYSIS OF PYRIMIDINES AND THEIR DIHYDROGENATED METABOLITES, Journal of liquid chromatography & related technologies, 20(19), 1997, pp. 3155-3172
Authors:
GAMELIN E
LEBOUIL A
BOISDRONCELLE M
TURCANT A
DELVA R
CAILLEUX A
KRIKORIAN A
BRIENZA S
CVITKOVIC E
ROBERT J
LARRA F
ALLAIN P
Citation: E. Gamelin et al., CUMULATIVE PHARMACOKINETIC STUDY OF OXALIPLATIN, ADMINISTERED EVERY 3WEEKS, COMBINED WITH 5-FLUOROURACIL IN COLORECTAL-CANCER PATIENTS, Clinical cancer research, 3(6), 1997, pp. 891-899
Authors:
GOSSE S
SAUVAIGO S
DAVER A
LARRA F
SAAVEDRA J
MARCHAND J
BERNARDGALLON D
BIGNON YJ
Citation: S. Gosse et al., EVALUATION OF THE AUTOMATED FLUORESCENT ANALYSIS OF THE H-RAS MINISATELLITE AFTER OPTIMIZED PCR AMPLIFICATION IN COMPARISON WITH A STANDARDIZED SOUTHERN BLOT TECHNIQUE, International journal of oncology, 10(4), 1997, pp. 735-740
Authors:
LAMEZEC B
ALLEAUME C
GAMELIN E
GOUDIER MJ
CAILLEUX PE
DANQUECHINDORVAL E
SIRE M
MAILLET ML
MAIGRE M
GESTA P
MAILLART P
LARRA F
Citation: B. Lamezec et al., LONG-TERM WEEKLY TREATMENT OF ADVANCED COLORECTAL-CANCER (CRC) WITH FLUOROURACIL (5-FU) AND LEUCOVORIN (LV) - 5 YEAR-RESULTS OF A MULTICENTRIC PHASE-II TRIAL OF 5-FU PHARMACOKINETIC MONITORING IN 152 PATIENTS, European journal of cancer, 33, 1997, pp. 726-726
OXALIPLATIN (LOHP) AND 5-FLUOROURACIL (5-FU) SYNERGISM IN ADVANCED COLORECTAL-CANCER PATIENTS (ACRC)
Authors:
MEYER V
DELVA R
GAMELIN E
LAMEZEC B
MAILLART P
DANQUECHINDORVAL E
LORTHOLARY A
BOISDRONCELLE M
MAIGRE M
BRIENZA S
CVITKOVIC E
LARRA F
Citation: V. Meyer et al., OXALIPLATIN (LOHP) AND 5-FLUOROURACIL (5-FU) SYNERGISM IN ADVANCED COLORECTAL-CANCER PATIENTS (ACRC), European journal of cancer, 33, 1997, pp. 746-746
Authors:
PAINBENI T
GAMELIN E
CAILLEUX A
LEBOUIL A
BOISDRONCELLE M
DAVER A
LARRA F
ALLAIN P
Citation: T. Painbeni et al., PLASMA SIALIC-ACID AS A MARKER OF THE EFFECT OF THE TREATMENT ON METASTATIC COLORECTAL-CANCER, European journal of cancer, 33(13), 1997, pp. 2216-2220
Authors:
MURATET JP
GIRAUD P
DAVER A
MINIER JF
GAMELIN E
LARRA F
Citation: Jp. Muratet et al., PREDICTING THE EFFICACY OF FIRST I-131 TREATMENT IN DIFFERENTIATED THYROID-CARCINOMA, The Journal of nuclear medicine, 38(9), 1997, pp. 1362-1368
Authors:
MURATET JP
GIRAUD P
DAVER A
MINIER JF
LARRA F
Citation: Jp. Muratet et al., DO SCANNING DOSES OF I-131 STUN THYROID REMNANTS - A COMPARISON OF 37VS 111 MBQ BEFORE FIRST I-131 ABLATIVE THERAPY IN PATIENTS WITH DIFFERENTIATED THYROID-CARCINOMA, The Journal of nuclear medicine, 38(5), 1997, pp. 163-163
Authors:
JEANFAIVRE T
CHASSEVENT A
GESLIN J
LARRA F
TUCHAIS E
Citation: T. Jeanfaivre et al., PROGNOSTIC-SIGNIFICANCE OF FLOW-CYTOMETRY IN SQUAMOUS-CELL BRONCHOGENIC CANCER - RETROSPECTIVE STUDY OF 61 CASES, Bulletin du cancer, 84(6), 1997, pp. 597-602
Authors:
BAUDET C
CHEVALIER G
CHASSEVENT A
CANOVA C
FILMON R
LARRA F
BRACHET P
WION D
Citation: C. Baudet et al., 1,25-DIHYDROXYVITAMIN-D3 INDUCES PROGRAMMED CELL-DEATH IN A RAT GLIOMA CELL-LINE, Journal of neuroscience research, 46(5), 1996, pp. 540-550
Authors:
DELVA R
MEGE M
GAMELIN E
MAILLART P
LORTHOLARY A
GUERIN O
PEIN F
LARRA F
Citation: R. Delva et al., PRESENTATION OF THE DOSE-INTENSITY FROM A N ASSOCIATION CARBOPLATIN-CYCLOPHOSPHAMIDE-ETOPOSID FOR WOMEN OLDER THAN 70 PRESENTING AN OVARIAN-CARCINOMA, Bulletin du cancer, 83(1), 1996, pp. 63-69
Authors:
GAMELIN E
DELVA R
DUMASNIL Y
JACOB J
MAILLART P
CALLE MB
GOUDIER MJ
LORTHOLARY A
HARDOUIN A
GESLIN J
HETROY J
LARRA F
Citation: E. Gamelin et al., HIGH-DOSE 5FU BIOMODULATION BY HIGH-DOSE LEUCOVORIN AND INDIVIDUAL 5FU DOSE ADJUSTMENT IN METASTATIC COLORECTAL-CANCER - A MULTICENTRIC PROSPECTIVE-STUDY OF 130 PATIENTS, European journal of cancer, 31A, 1995, pp. 729-729
Authors:
MAILLART P
LORIMIER G
GAMELIN E
DELVA R
LORTHOLARY A
MEYER V
GUERIN J
GIRAUD C
LARRA F
Citation: P. Maillart et al., TOTALLY IMPLANTABLE VENOUS ACCESS DEVICES (TTVAD) IN CANCEROLOGY - RESULTS OF 141 PERCUTANEOUS CANNULATION, European journal of cancer, 31A, 1995, pp. 892-892
Authors:
DELVA R
LEYNIA P
GAMELIN E
LORTHOLARY A
MAILLART P
GUERIN O
LARRA F
Citation: R. Delva et al., CLINICAL AND ECONOMICAL EFFICACY FROM A NEW DECISION TREE FOR THE USEOF ANTIEMETIC TREATMENTS, European journal of cancer, 31A, 1995, pp. 1232-1232
Authors:
GAMELIN E
ALLAIN P
MAILLART P
TURCANT A
DELVA R
LORTHOLARY A
LARRA F
Citation: E. Gamelin et al., LONG-TERM PHARMACOKINETIC BEHAVIOR OF PLATINUM AFTER CISPLATIN ADMINISTRATION, Cancer chemotherapy and pharmacology, 37(1-2), 1995, pp. 97-102
Authors:
JEANFAIVRE T
CHASSEVENT A
BERRUCHON J
SAVARY L
CHRETIEN MF
GESLIN J
LARRA F
TUCHAIS E
Citation: T. Jeanfaivre et al., PROGNOSTIC ASSESSMENT OF SMALL-CELL LUNG- CANCER BY FLOW-CYTOMETRY, Bulletin du cancer, 82(5), 1995, pp. 364-370
Authors:
JEANFAIVRE T
CHASSEVENT A
LARRA F
TUCHAIS E
Citation: T. Jeanfaivre et al., STATEMENT ABOUT THE CONTRIBUTION OF DNA C ONTENT IN PROGNOSIS OF NONSMALL CELL LUNG-CANCER - REVIEW OF THE LITERATURE, Bulletin du cancer, 81(7), 1994, pp. 605-609